Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: Results of an Italian Association of Medical Oncology (AIOM) survey

Chiara Catania, V. Zagonel, V. Fosser, N. La Verde, O. Bertetto, C. Lacono, M. Venturini, D. Radice, L. Adamoli, F. Boccardo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Advance directives, acceleration of death, euthanasia and 'life-sustaining treatment' have sparked much heated debate among the media, the public, doctors and political leaders. We evaluate the personal opinions of Italian Association of Medical Oncology (AIOM) members. Patients and methods: A 30-item questionnaire was developed and delivered to all 1832 AIOM members. Results: Six-hundred and eighty-five (37%) oncologists completed and returned the questionnaires. Sixty-three per cent felt culturally and psychologically prepared to face these issues. Fifty-four per cent believed that what had been decided while the patient enjoyed good health is no longer applicable in an advanced state of terminal illness. Thirty-nine per cent believed that doctors should abide by these directives, while 49% believed that this should be discussed on a case-by-case basis. Fourteen per cent of oncologists were favourable towards euthanasia and 42% only in particular circumstances. Fifty-six per cent had received at least one request for accelerating death: 15% consented, 50% discussed it with the patient and 31% refused. Conclusion: Advance directives, euthanasia, accelerated death and life-sustaining treatment represent considerable challenges for Italian oncologists. Although prepared to face these issues, AIOM members ask for a debate within the medical world and for a shared judicial regulation.

Original languageEnglish
Pages (from-to)1947-1954
Number of pages8
JournalAnnals of Oncology
Volume19
Issue number11
DOIs
Publication statusPublished - 2008

Fingerprint

Euthanasia
Medical Oncology
Advance Directives
Therapeutics
Health
Surveys and Questionnaires
Oncologists

Keywords

  • Acceleration of death
  • Advance directives
  • Euthanasia
  • Life sustaining treatment
  • Oncological patients

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Opinions concerning euthanasia, life-sustaining treatment and acceleration of death : Results of an Italian Association of Medical Oncology (AIOM) survey. / Catania, Chiara; Zagonel, V.; Fosser, V.; La Verde, N.; Bertetto, O.; Lacono, C.; Venturini, M.; Radice, D.; Adamoli, L.; Boccardo, F.

In: Annals of Oncology, Vol. 19, No. 11, 2008, p. 1947-1954.

Research output: Contribution to journalArticle

@article{b68262e6da784e21a8e9293f9fb3879a,
title = "Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: Results of an Italian Association of Medical Oncology (AIOM) survey",
abstract = "Background: Advance directives, acceleration of death, euthanasia and 'life-sustaining treatment' have sparked much heated debate among the media, the public, doctors and political leaders. We evaluate the personal opinions of Italian Association of Medical Oncology (AIOM) members. Patients and methods: A 30-item questionnaire was developed and delivered to all 1832 AIOM members. Results: Six-hundred and eighty-five (37{\%}) oncologists completed and returned the questionnaires. Sixty-three per cent felt culturally and psychologically prepared to face these issues. Fifty-four per cent believed that what had been decided while the patient enjoyed good health is no longer applicable in an advanced state of terminal illness. Thirty-nine per cent believed that doctors should abide by these directives, while 49{\%} believed that this should be discussed on a case-by-case basis. Fourteen per cent of oncologists were favourable towards euthanasia and 42{\%} only in particular circumstances. Fifty-six per cent had received at least one request for accelerating death: 15{\%} consented, 50{\%} discussed it with the patient and 31{\%} refused. Conclusion: Advance directives, euthanasia, accelerated death and life-sustaining treatment represent considerable challenges for Italian oncologists. Although prepared to face these issues, AIOM members ask for a debate within the medical world and for a shared judicial regulation.",
keywords = "Acceleration of death, Advance directives, Euthanasia, Life sustaining treatment, Oncological patients",
author = "Chiara Catania and V. Zagonel and V. Fosser and {La Verde}, N. and O. Bertetto and C. Lacono and M. Venturini and D. Radice and L. Adamoli and F. Boccardo",
year = "2008",
doi = "10.1093/annonc/mdn381",
language = "English",
volume = "19",
pages = "1947--1954",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "11",

}

TY - JOUR

T1 - Opinions concerning euthanasia, life-sustaining treatment and acceleration of death

T2 - Results of an Italian Association of Medical Oncology (AIOM) survey

AU - Catania, Chiara

AU - Zagonel, V.

AU - Fosser, V.

AU - La Verde, N.

AU - Bertetto, O.

AU - Lacono, C.

AU - Venturini, M.

AU - Radice, D.

AU - Adamoli, L.

AU - Boccardo, F.

PY - 2008

Y1 - 2008

N2 - Background: Advance directives, acceleration of death, euthanasia and 'life-sustaining treatment' have sparked much heated debate among the media, the public, doctors and political leaders. We evaluate the personal opinions of Italian Association of Medical Oncology (AIOM) members. Patients and methods: A 30-item questionnaire was developed and delivered to all 1832 AIOM members. Results: Six-hundred and eighty-five (37%) oncologists completed and returned the questionnaires. Sixty-three per cent felt culturally and psychologically prepared to face these issues. Fifty-four per cent believed that what had been decided while the patient enjoyed good health is no longer applicable in an advanced state of terminal illness. Thirty-nine per cent believed that doctors should abide by these directives, while 49% believed that this should be discussed on a case-by-case basis. Fourteen per cent of oncologists were favourable towards euthanasia and 42% only in particular circumstances. Fifty-six per cent had received at least one request for accelerating death: 15% consented, 50% discussed it with the patient and 31% refused. Conclusion: Advance directives, euthanasia, accelerated death and life-sustaining treatment represent considerable challenges for Italian oncologists. Although prepared to face these issues, AIOM members ask for a debate within the medical world and for a shared judicial regulation.

AB - Background: Advance directives, acceleration of death, euthanasia and 'life-sustaining treatment' have sparked much heated debate among the media, the public, doctors and political leaders. We evaluate the personal opinions of Italian Association of Medical Oncology (AIOM) members. Patients and methods: A 30-item questionnaire was developed and delivered to all 1832 AIOM members. Results: Six-hundred and eighty-five (37%) oncologists completed and returned the questionnaires. Sixty-three per cent felt culturally and psychologically prepared to face these issues. Fifty-four per cent believed that what had been decided while the patient enjoyed good health is no longer applicable in an advanced state of terminal illness. Thirty-nine per cent believed that doctors should abide by these directives, while 49% believed that this should be discussed on a case-by-case basis. Fourteen per cent of oncologists were favourable towards euthanasia and 42% only in particular circumstances. Fifty-six per cent had received at least one request for accelerating death: 15% consented, 50% discussed it with the patient and 31% refused. Conclusion: Advance directives, euthanasia, accelerated death and life-sustaining treatment represent considerable challenges for Italian oncologists. Although prepared to face these issues, AIOM members ask for a debate within the medical world and for a shared judicial regulation.

KW - Acceleration of death

KW - Advance directives

KW - Euthanasia

KW - Life sustaining treatment

KW - Oncological patients

UR - http://www.scopus.com/inward/record.url?scp=54949100788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54949100788&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdn381

DO - 10.1093/annonc/mdn381

M3 - Article

C2 - 18556665

AN - SCOPUS:54949100788

VL - 19

SP - 1947

EP - 1954

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 11

ER -